Study tour “Austrian Life Science Innovation Ecosystem” in Vienna
The Human Technopole Centre for Innovation and Technology Transfer (CITT) continues its international promotion activities by learning about foreign innovation ecosystems.
Last November 2023, the CITT organised a study tour to meet the leading players in basic and applied research within the Austrian ecosystem, with the support of the Italian Embassy in Vienna and the Italian Trade Agency.
ABOUT THE STUDY TOUR
Over two intense days, the CITT team traveled with a delegation of TTOs and professionals engaged in enhancing research results within Italian research centers, universities, and research hospitals to investigate how innovation is generated in Austria and which players are involved.
The goals of the visit, led by Fabio Terragni – member of the HT Management Committee delegate for tech transfer – have been multiple: understand the peculiarities of the Austrian innovation ecosystem, meet its active players, learn about good practices and the reference framework (standards, incentives, available funding), also to identify potential areas of teamwork among the two countries.
PROGRAMME
- On November 29, honored by the welcome of H.E. ambassador Stefano Beltrame, the delegation gathered at Palazzo Metternich (the Italian Embassy in Vienna) to meet and hear from the most prominent drivers of innovation in Austria – FFG, Lisavienna, Vienna Business Agency (VBA), Austrian Business Agency (ABA) – about several topics, i.e., the relevant framework, available funding, and best practices in the life sciences. Presentations ended with insights about two successful startups, Solgate and Proxygen. Fabio Terragni, member of the HT management committee and delegate for tech transfer, presented Human Technopole and the activities related to tech transfer.
- On November 29 and 30, the delegation visited three major research centres: the Vienna BioCenter (IMBA-GMI, INiTS, University of Vienna, Medical University of Vienna), ISTA, and CeMM; all leading players in basic and applied research within the Austrian ecosystem.
We thank the Italian Embassy in Vienna and the Italia Trade Agency for their invaluable support in organizing the initiative.
Big thanks to Angelo Nuzzo (FFG), Elvira Kainersdorfer (LISAvienna), Birgit Reiter-Braunwieser (ABA), Christian Frey and Daniel Chaldek (VBA), Enrico Girardi (Solgate), Matthias Brand (Proxygen), Markus Pietzka (INiTS), Raphaela Freidl (University of Vienna), Andrea Kolbus (Medical University of Vienna), Markus Wanko and Alexander Schwartz (xista), Prudence Donovan and Giulio Superti-Furga (CeMM) for sharing their expertise and leaving us with so many takeaways.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.